Ginkgo Biloba's Effects on Memory and Brain Health Markers
Part of Brain & nervous system, Mental health clinical trials.
This study tests whether Ginkgo biloba extract can improve blood markers and cognitive function in people with mild cognitive impairment (early memory loss). Researchers will measure changes in blood biomarkers to understand how Ginkgo may help protect brain health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 20 or older
- Diagnosed with mild cognitive impairment (CDR score of 0.5)
- Your doctor thinks Ginkgo biloba treatment is appropriate for you
- Not currently taking dementia medications like donepezil, rivastigmine, or galantamine
- No bleeding disorders or use of blood-thinning medications (like warfarin, aspirin, clopidogrel)
- Not allergic to Ginkgo biloba or unable to tolerate lactose or galactose
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a natural extract from ginkgo biloba can help people with mild memory or thinking problems caused by small vessel disease in the brain. It looks for adults aged 50 to 75 who have had these symptoms for at least 3 months but can still live independently.
This trial studies EGb 761 to see if it can improve symptoms in people with mild cognitive impairment (early memory/thinking changes) who also have signs of brain blood vessel disease. It may help by targeting the brain changes seen on scans.
This Phase 1 study tests whether Centella asiatica (a plant-based supplement) is safe and reaches its intended target in people with mild cognitive impairment or early Alzheimer’s disease. It also checks how it affects memory-related brain measures like MRI scans, which is why multiple scans are required.
This trial studies a non-medication (non-drug) program to improve memory and daily thinking in people with mild cognitive impairment or mild Alzheimer’s disease. It may help by supporting brain function and monitoring symptoms over time.
This study tests whether a special drink containing medium-chain triglycerides (MCTs, a type of fat) and B vitamins can help support memory and thinking in older adults with mild cognitive impairment (MCI). You would take the drink daily for 18 months and have regular check-ins including memory tests.
This trial tests whether a specific ginkgo biloba extract (EGb761) can improve thinking and memory in people with mild cognitive impairment (MCI). It also looks at changes in blood markers related to the condition.
Hear when a new Mild Cognitive Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.